Filing Details
- Accession Number:
- 0000899243-17-017080
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-23 16:10:59
- Reporting Period:
- 2017-06-22
- Filing Date:
- 2017-06-23
- Accepted Time:
- 2017-06-23 16:10:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1520697 | Acadia Healthcare Company Inc. | ACHC | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1421620 | B Reeve Waud | C/O Waud Capital Partners, L.l.c. 300 N. Lasalle Street, Suite 4900 Chicago IL 60654 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.01 Per Share | Disposition | 2017-06-22 | 50,000 | $47.51 | 3,471,681 | No | 4 | S | Indirect | See Footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnotes |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, Par Value $0.01 Per Share | 6,110 | Direct |
Footnotes
- Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the "Halcyon Trust") on March 17, 2017.
- The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $47.50 to $47.57, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- The shares are owned of record as follows: (i) 428,032 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 782,511 shares by Waud Capital Partners QP II, L.P. ("WCP QP II"), (iii) 119,425 by WCP FIF II (Acadia), L.P. ("WCP FIF II"), (iv) 122,311 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II"), (v) 62,770 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III"), (vi) 170,501 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III"), (vii) 388,500 shares by Waud Capital Partners QP III, L.P. ("WCP QP III"), (viii) 68,701 shares by Waud Capital Partners III, L.P. ("WCP III"), (ix) 431,113 shares by the Halcyon Trust, (x) 31,324 shares by Waud Family Partners, L.P. ("WFP LP"), (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 37,493 shares by WCP LLC and (xiii) 795,667 shares by Crystal Cove LP.
- Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III.
- Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP.
- Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.
- Represents shares held of record for the benefit of WCP LLC.